Abstract
The aim of this study was to understand the mode of action of tea polyphenol epigallocatechin gallate (EGCG) in vivo. Swiss albino mice were treated i.p. with EGCG at two different doses i.e. 12-mg/kg body weight and 15-mg/kg body weight, for 7 days prior to inoculation of Sarcoma180 (S180) cells and continued for another 7 days. The growth of the S180, harvested 7 days after inoculation, was significantly reduced due to treatment with EGCG. The flowcytometric analysis of S180 cells, showed significant increase in apoptosis and reduction in the number of cells in G2/M phase of cell cycle due to treatment with EGCG. The induction of apoptosis has also been confirmed by the TUNEL and DNA fragmentation assays. Both RT-PCR and Western blot analysis showed significant up-regulation of p53 and bax, and down-regulation of bcl-2 and c-myc due to EGCG treatment. No changes in the expression pattern of p21, p27, bcl-xl, mdm2 and cyclin D1 were seen. Interestingly, there was significant down-regulation of spliceosomal uridylic acid rich small nuclear RNAs (UsnRNAs) U1B and U4-U6 due to EGCG treatment. This indicates that these UsnRNAs may be involved in the apoptosis process. Taken together, our study suggests that in vivo EGCG could induce apoptosis in S180 cells through alteration in G2/M phase of the cell cycle by up-regulation of p53, bax and down-regulation of c-myc, bcl-2 and U1B, U4-U6 UsnRNAs.
Similar content being viewed by others
References
Yang CS, Maliakal P, Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25−4
Weisburger JH (1999) Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 220:271−75
Adhami VM, Afaq Farrukh, Ahamad N, Hara Y, Mukhtar H (2004) Tea polyphenols as cancer chemopreventive agents. In: Kelloff GJ, Hawk ET, Sigman CC (eds), Cancer chemoprevention, promising cancer chemoprevention agents. Humana Press Inc., Totowa, NJ, vol 1, pp 437−49
Lin JK, Liang YC (2000) Cancer chemoprevention by tea polyphenols. Proc Natl Sci Counc 24(1):1−3
Qanungo S, Das M, Haldar S, Basu A (2005) Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26(5):958−67
Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma. J Natl Cancer Inst 89(24):1881−886
Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong A-NT (2003) Epigallocatechin -3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24(8):1369−378
Jia X, Han C, Chen J (2002) Effects of tea on preneoplastic lesions and cell cycle regulators in rat liver. Cancer Epidemiol Biomarkers Prevention 11:1663−667
Gupta S, Hastak K, Ahamad N, Lewin JS, Mukhtar H (2001) The inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Nat Acad Sci 98(18):10350−0355
Bhattacharyya A, Choudhury T, Pal S et al (2003) Apoptogenic effects of black tea on Ehrlich’s ascites carcinoma cell. Carcinogenesis 24(1):75−0
Bode AM, Dong Z (2003) Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 36(1):66−7
Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3:768−80
Kuo PL, Lin CC (2003) Green tea constituent (−)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53 dependent and Fas-mediated pathways. J Biomed Sci 10:291−97
Ju J, Hong J, Zhou JN et al (2005) Inhibition of intestinal tumorigenesis in Apcmin/+mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65(22):10623−0631
Ran ZH, Jou J, Xiao SD (2005) Experimental study on anti-neoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas. Chin Med J Engl 118(16):1330−337
Levites Y, Amit T, Youdim MB, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277(34):30574−0580
Huh SW, Bae SM, Kim YW et al (2004) Anticancer effects of (−)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gyneocol Oncol 94(3):760−68
Gupta S, Hussain T, Mukhtar H (2003) Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410(1):177−85
Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Current opinion Cell Biol 13:738−47
Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26(8):1317−322
Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21(3):485−95
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803−815
Gridasova AA, Henry RW (2005) The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerase II and III independently of sequence-specific DNA binding. Mol cell Biol 25(8):3247−260
Crains CA, White RJ (1998) p53 is a general repressor of RNA polymerase III transcription. EMBO J 17:3112−123
Chesnokov I, Chu WM, Botchan MR, Schmid CW (1996) p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol Cell Biol 16:7084−088
Manna S, Banerjee S, Saha P, Roy A, Das S, Panda CK (2006) Differential alterations in metabolic pattern of the spliceosomal UsnRNAs during pre-malignant lung lesions induced by benzo(a)pyrene: modulation by tea polyphenols. Mol Cell Biochem (in press)
Ray R, Ray K, Panda CK (1997) Differential alterations in metabolic pattern of the six major UsnRNAs during development. Mol Cell Biochem 177:79−8
Lund E, Kahan B, Dahlberg JE (1985) Differential control of U1 small nuclear RNA expression during mouse development. Science 229(4719):1271−274
Lund E, Dahlberg JE (1987) Differential accumulation of U1 and U4 small nuclear RNAs during Xenopus development. Genes Dev 1(1):39−6
Hanley BA, Schuler MA (1991) Developmental expression of plant snRNAs. Nucl Acids Res 19(22):6319−325
Forbes DJ, Kirschner MW, Caput D, Dahlberg JE, Laund E (1984) Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis. Cell 38(3):681−89
Dahlberg JE, Lund E (1987) Structure and expression of U-snRNA genes. Mol Biol Rep 12(3):139−43
Reddy R, Henning D, Busch H (1979) Nucleotide sequence of nuclear U3B RNA. J Biol Chem 254(21):11097−1105
Degen WGJ, Aarssen YV, Pruijn GJM, Utz PJ, Venrooij WJV (2000) The fate of U1 snRNP during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule. Cell Death Differentiation 7:70−9
Siddiqi M, Das S (1999) Tea as anticarcinogenic agent. In: Jain NK (ed), Global Advances in Tea Science. Aravali Books International, New Delhi, pp 359−68
Banerjee S, Manna S, Saha P, Panda CK, Das S (2005) Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev 14(3):215−21
Ganguly C, Saha P, Panda CK, Das S (2005) Inhibition of growth, induction of apoptosis and alteration of gene expression by tea polyphenols in the highly metastatic human lung cancer cell line NCI-H460. Asian Pac J Cancer Prev 6(3):326−31
Saha P, Banerjee S, Ganguly C, Manna S, Panda CK, Das S (2005) Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Envir Pathol Toxicol Oncol 24(3):211−24
Holmes KL, Otten G, Yokoyama WM (2001) Flow cytometry analysis using the Becton Dickinson FACS Calibur. In: Coligan JE, Bierrer BE, Margulies DH, Shevach EM, Strober W (eds) Current protocols in immunology. John Wiley & Sons Inc., USA, vol 1, pp 5.4.1−.4.22
Yoshida A, Shao R, Pommier Y (1999) Assessment of DNA damage in apoptosis. In: Studzinski GP (ed) Apoptosis: a practical approach. Oxford University Press, New York, pp 41−5
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
Hernandez I, Maddison LA, Wei Y, et al. (2003) Prostate-specific expression of p53R172L differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res 1:1036−047
Tsuruyama T, Nakamura T, Jin G, Ozeki M, Yamada Y, Hiai H (2002) Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice. Proc Nat Acad Sci 99(12):8253−258
Pereira MA, Kramer PM, Conran PB, Tao L (2001) Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice. Carcinogenesis 22(9):1511−519
Wu C, Fujihara H, Yao J et al (2003) Different expression patterns of Bcl-2, Bcl-xl and Bax proteins after sublethal forebrain ischemia in C57black/Crj6 mouse Striatum. Stroke 34:1803−808
Wang X, Michael D, Murcia GD, Oren M (2002) P53 activation by nitric oxide involves down-regulation of mdm2. J Biol Chem 277(18):15697−5702
Castro IPD, Malumbres M, Santos J, Pellicer A, Piqueras JF (1999) Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Carcinogenesis 20(9):1675−682
Pereira MA, Li Y, Gunning WT et al (2002) Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 23(7):1185−192
Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D (2002) Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. British J Cancer 86:443−48
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond 227:680−85
Choudhury K, Choudhury I, Jones RW, Thirunavukkarasu C, Eliceiri GL (1988) Metabolism of U6 RNA species in nonirradiated and UV-irradiated mammalian cells. J Cell Physiol 137(3):529−36
Sherr CJ (1996) Cancer cell cycles. Science 274:1672−677
Pelengaris S, Khan M, Evan G (2002) C-Myc: more than just a matter of life and death. Nature Reviews Cancer 2:764−76
Vargas DA, Ronai Z (2002) P53-Mdm2-the affair that never ends. Carcinogenesis 23(4):541−47
Fujiki H, Suganuma M, Okabe S et al (1998) Cancer inhibition by green tea. Mutant Res 402(1−):307−10
Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H (1997) Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 88(7):639−43
Ahmad N, Cheng P, Mukhtar H (2000) Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275(2):328−34
Boxer LM, Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene 20:5595−610
Masuda M, Suzui M, Weinstein IB (2001) Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clinical Cancer Res 7:4220−229
Hamad K, Kumazaki T, Mizuno K, Yokoro K (1989) A small nuclear RNA U5, can transform cells in vitro. Mol Cell Biol 9(10):4345−356
Eliceiri BP, Choudhury K, Scott QO, Eliceiri GL (1989) Ultraviolate light-induced inhibition of small nuclear RNA synthesis. J Cell Physiol 138(3):586−92
Thirunavukkarasu C, Choudhury K, Ninichuck AJ, Choudhury I, Eliceiri G (1988) Effect of ultraviolate light on the expression of genes for human U1 RNA. J Cell Physiol 137(1):55−4
Morra DS, Eliceiri BP, Eliceiri GL (1986) Effect of UV light on small nuclear RNA synthesis: increased inhibition during postirradiation cell incubation. Mol Cell Biol 6(3):745−50
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manna, S., Banerjee, S., Mukherjee, S. et al. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: Mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression. Apoptosis 11, 2267–2276 (2006). https://doi.org/10.1007/s10495-006-0198-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-006-0198-2